For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250203:nRSC5556Va&default-theme=true
RNS Number : 5556V Indivior PLC 03 February 2025
Indivior Appoints Daniel A. Ninivaggi to the Board
Richmond, VA, February 3, 2025 - Further to the announcement made on Tuesday
January 28, the Board of Directors of Indivior PLC is pleased to announce the
appointment of Daniel A. Ninivaggi to the Board as an Independent
Non-Executive Director with effect from January 31, 2025.
Mr. Ninivaggi has significant public company experience as a director and
executive and brings to Indivior a strong background in operations and capital
allocation, as well as legal and finance expertise.
Mr. Ninivaggi has also been appointed a member of the Nomination Committee.
Comment by Dr. David Wheadon, Chair
"I am pleased to announce Dan's appointment to the Board. As a seasoned public
company executive, we are delighted that Indivior will be able to benefit from
his significant board and operational experience as we work together to
deliver value to all Indivior stakeholders."
Comment by Daniel Ninivaggi
"I welcome the opportunity to join the Board of Indivior. I believe Indivior
has an important mission in helping to transform the lives of patients
struggling with opioid use disorder. I look forward to working closely with
the Board and management team to realize Indivior's full potential as a global
leader in developing and commercializing novel opioid use disorder
treatments."
Daniel Ninivaggi Biography
Daniel A. Ninivaggi is currently Chairman of Garrett Motion Inc. (NASDAQ:GTX),
a Switzerland-based supplier of turbochargers and other products designed to
improve energy efficiency and reduce emissions in vehicles and industrial
equipment. From August 2021 until March 2024, Mr. Ninivaggi formerly served as
the Chief Executive Officer and subsequently the Executive Chairman of
Lordstown Motors Corp, an electric vehicle automaker. Prior to that, Mr.
Ninivaggi served as the President and Chief Executive Officer of Icahn
Enterprises L.P. (IEP) (NASDAQ:IEP), the principal investment vehicle of Carl
Icahn, between 2010 and 2014; Co-Chief Executive Officer of Federal-Mogul
Holdings Corp. (a public-company subsidiary of IEP now part of Apollo Global
Management) from 2014 until 2017; and Chief Executive Officer of Icahn
Automotive Group, LLC and a Managing Director of IEP from 2017 until
2019. Prior to joining IEP, Mr. Ninivaggi spent six years at Lear
Corporation (NYSE:LEA), holding various senior executive positions.
Mr. Ninivaggi has served as a director of numerous public and private
companies, including Garrett Motion Inc., Lordstown Motors Corp., Hertz Global
Holdings Inc., Navistar International Corporation, Icahn Enterprises G.P. Inc.
(the general partner of Icahn Enterprises), CVR Energy Inc., LLC, XO Holdings,
Tropicana Entertainment Inc., Motorola Mobility Holdings Inc., and CIT Group,
Inc.
Mr. Ninivaggi began his career at Skadden, Arps, Slate, Meagher & Flom LLP
before joining Winston & Strawn LLP, where he became a partner
specializing in mergers & acquisitions, financing transactions and
corporate governance. . He holds a Bachelor of Arts degree from Columbia
University, an MBA from the University of Chicago Graduate School of Business,
and a law degree (Juris Doctor) (with distinction) from Stanford University
School of Law.
About Indivior
Indivior is a global pharmaceutical company working to help change patients'
lives by developing medicines to treat substance use disorders (SUD). Our
vision is that all patients around the world will have access to
evidence-based treatment for the chronic conditions and co-occurring disorders
of SUD. Indivior is dedicated to transforming SUD from a global human crisis
to a recognized and treated chronic disease. Building on its global portfolio
of OUD treatments, Indivior has a pipeline of product candidates designed to
expand on its heritage in this category. Headquartered in the
United States in Richmond, VA, Indivior employs over 1,000 individuals
globally and its portfolio of products is available in over 30 countries
worldwide. Visit www.indivior.com
(https://nam12.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.indivior.com%2F&data=05%7C02%7Cdavid.wisniewski%40Indivior.com%7C46151793371f4a5a147b08dced4812d0%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C638646141028285945%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=vwwjBavEG8GHlzYIHaEEC6eKfaZlLZYEsM1w5sIS1B8%3D&reserved=0)
to learn more. Connect with Indivior on LinkedIn by
visiting www.linkedin.com/company/indivior
(https://nam12.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.linkedin.com%2Fcompany%2Findivior&data=05%7C02%7Cdavid.wisniewski%40Indivior.com%7C46151793371f4a5a147b08dced4812d0%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C638646141028306668%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=mWdLO9fvlp1vQv6%2F30I2DGhuwyieW3W262QTgrk4ZVQ%3D&reserved=0)
.
For Further Information
Investor Enquiries Jason Thompson VP, Investor Relations +1 804 402 7123
Indivior PLC jason.thompson@indivior.com
Tim Owens Director, Investor Relations Indivior PLC +1 804 263 3978
timothy.owens@indivior.com
Media Enquiries Jonathan Sibun Teneo +44 (0)20 7353 4200
U.S. Media Inquiries +1 804 594 0836
Indiviormediacontacts@indivior.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAUAUURVSUURAR